Loading...
Market
David Baker's team partners with major pharmaceutical company by mid-2025?
3
Resolution / Starting Odds
Yes • 50%
No • 50%
Official press releases or credible news outlets
Story
AI Creates Experimental Treatment for Neglected Disease, Aiming to Democratize Drug Discovery by David Baker's Team
Jan 16, 2025, 12:08 PM
Researchers have developed an experimental treatment for a neglected disease using artificial intelligence, marking a significant advancement in drug discovery. The project, led by Nobel laureate David Baker and researcher Susana Vaz Torres, aims to 'democratize' the development of therapies that have been largely ignored by major pharmaceutical companies. This breakthrough was achieved through the application of AI technologies in the discovery process, showcasing the potential of AI to transform healthcare and address unmet medical needs.
View original story
Similar markets
Roche • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
The Nature Conservancy • 25%
WWF • 25%
Conservation International • 25%
Other • 25%
No • 50%
Yes • 50%
Pfizer • 25%
Johnson & Johnson • 25%
Other • 25%
Novo Nordisk • 25%
